CClinicalTrials.gg
Status unknownNCT05158790Updated Jan 5, 2022

Impact of Covid-19 on Training for ENT and Cervico-Facial Surgery Residents in France

An observational study in Cervico-Facial Surgery ENT Academic Medical and Surgical Training in France and Cervico-Facial Surgery ENT Medical Residency (Auvergne-Rhône-Alpes, Grand Est, Ile de France, Nouvelle Aquitaine and Provence-Alpes-Côte d'Azur Areas), sponsored by University Hospital, Strasbourg, France. Status unknown at 6 sites in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-05.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
80
Ages
18 Years and older
Sex
All
01

Study summary

The impact of the Covid-19 pandemic on medical education is real but little known.

ENT interns were directly affected by the management of Covid-19 patients (performing surgical tracheostomies), many conferences and trainings were cancelled, their usual hospital activity deeply reshuffled.

Although each student has a personal story of the impact of Covid-19 on their training, there is no doubt that the effects of Covid-19 are felt at scale. This study aims to investigate the effect of the pandemic on the medical and surgical training of ENT and Cervico-Facial Surgery interns in France from November 2019 to May 2021 (Auvergne-Rhône-Alpes, Grand Est, Ile de France, Nouvelle Aquitaine and Provence-Alpes-Côte d'Azur areas). A questionnaire will be sent by mail to ENT interns in France to assess the impact of Covid-19 on the training of ENT interns in France.

02

Conditions studied

  • Cervico-Facial Surgery ENT Academic Medical and Surgical Training in France
  • Cervico-Facial Surgery ENT Medical Residency (Auvergne-Rhône-Alpes, Grand Est, Ile de France, Nouvelle Aquitaine and Provence-Alpes-Côte d'Azur Areas)

Browse trials for

Keywords

  • Covid 19
  • Head and neck surgery
  • Residency
  • Medical training
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 80 is below the median of 260 across 3,135 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

ENT residents in France (Auvergne-Rhône-Alpes, Grand Est, Ile de France, Nouvelle Aquitaine and Provence-Alpes-Côte d'Azur regions) during the period from November 2019 to May 2021.

Inclusion criteria

  • Age > 18 years
  • ENT residents in France (Auvergne-Rhône-Alpes, Grand Est, Ile de France, Nouvelle Aquitaine and Provence-Alpes-Côte d'Azur regions) during the period from November 2019 to May 2021.
  • Informed of the objectives of the research and not objecting to the processing of their data

Exclusion criteria

Exclusion Criteria:

  • Subjects in research year, on availability, or in off-track training
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
80 participants (estimated)
Patient registry
No

Interventions

  • OtherQuestionnaire

    Administration of a questionnaire

06

What researchers measure

Primary outcomes

  1. To evaluate the impact of Covid-19 on the training of ENT interns in France

    Evaluate the reduction in training time (practical and theoretical) as a proportion of usual training time between 2 periods: before and during the acute phase of the pandemic from November 2019 to May

    Time frame: before and during the acute phase of the pandemic from November 2019 to May 2021 (ordinal categorical primary endpoint)

Secondary outcomes

  1. Assess interregional disparities in the impact of the Covid-19 crisis on ENT interns' training time.

    Comparison of the reduction of time dedicated to training (practical and theoretical) between different regions of France. Percentage of time spent in the operating room, duty, on-call, DES course, IUD Comparison of the reduction of time dedicated to training (practical and theoretical) between different regions of France. Percentage of time spent in the operating room, duty, on-call, DES course, IUD.

    Time frame: before and during the acute phase of the pandemic, from November 2019 to May 2021

  2. Evaluate strategies implemented to compensate for block closure and theoretical course cancellations between waves

    Descriptive qualitative analysis of the strategies implemented.

    Time frame: Before and during the acute phase of the pandemic, from November 2019 to May 2021

  3. Evaluate interregional disparities in training time for ENT interns outside the Covid-19 period.

    Comparison of the time dedicated to training (practical and theoretical) between different regions of France over a given period (pre-Covid19)

    Time frame: Before and during the acute phase of the pandemic, from November 2019 to May 2021

07

Study locations

6 of 6 sites recruiting
  • Service d'ORL et de Chirurgie Cervico-Faciale CHU Henri Mondor, APHP
    Créteil, 94000, France
    Recruiting
  • Service d'ORL et de Chirurgie Cervico-Faciale Hôpital Bicêtre, APHP
    Le Kremlin-Bicêtre, 94270, France
    Recruiting
  • Département d'ORL et de Chirurgie Cervico-Faciale Hôpital Gui de Chauliac, CHU de Montpellier
    Montpellier, 34295, France
    Recruiting
  • Service d'ORL et de Chirurgie Cervico-Faciale, Hôpital Lyon Sud
    Pierre-Bénite, 69310, France
    Recruiting
  • Service d'ORL et de Chirurgie Cervico-Faciale, CHU de Poitiers
    Poitiers, 86021, France
    Recruiting
  • Service d'ORL et de Chirurgie Cervico-Faciale Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
    Strasbourg, 67098, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05158790
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Dec 15, 2021
Start date
Nov 30, 2021
Primary completion
Feb 28, 2022 (estimated)
Completion
Feb 28, 2022 (estimated)
Last update
Jan 5, 2022

Study contacts

Léa fath, MD
Contact
lea.fath@chru-strasbourg.fr
33.3.88.12.64.98

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion